BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

NCT07583303 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography Test
DRUG: Fludarabine
PROCEDURE: Leukapheresis
DRUG: Single Agent Therapy

Sponsor

City of Hope Medical Center

Collaborators

[object Object]